Literature DB >> 15496677

Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment.

Hani Houshyar1, Sotara Manalo, Mary F Dallman.   

Abstract

Chronic stressors alter brain function and may leave traces after their relief. We used intermittent morphine treatment to examine the relationships between stress-induced changes in energy balance and hypothalamo-pituitary-adrenal (HPA) activity and the recovery thereafter. We studied the effects of morphine injections on energy balance, hormones and fat stores, brain neuropeptide expression, and the ACTH and corticosterone responses to restraint 12 hr after the final injection and 8 d later during recovery. Weight gain, food intake, and caloric efficiency decreased at morphine onset, and these were maintained throughout the morphine injections. At 12 hr, fat stores, leptin, insulin, and testosterone concentrations were reduced. Subsequently, body weight gain and food intake increased and caloric efficiency was above control during the final days. By the eighth recovery day, fat stores and peripheral hormones were no longer depressed. At 12 hr, an over-response of CRF mRNA to restraint occurred in the hypothalamus, similar to the facilitated ACTH and corticosterone responses. On day 8, the hypothalamic CRF mRNA response to restraint was still facilitated, opposite to inhibited ACTH responses. Hypothalamic CRF mRNA correlated highly with mesenteric fat weight in morphine-treated rats. We conclude that there is a prolonged recovery from chronic stressors involving interrelated changes in energy balance and HPA activity. Nonetheless, 8 d after withdrawal from morphine, rats still display facilitated central stress responses, similar to the HPA symptoms described in posttraumatic stress disorder patients. Repeated partial withdrawal associated with intermittent morphine treatment, compounded by complete withdrawal associated with termination of the treatment, is likely required for these metabolic and HPA derangements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496677      PMCID: PMC6730111          DOI: 10.1523/JNEUROSCI.1641-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  26 in total

1.  CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.

Authors:  Javier Navarro-Zaragoza; Cristina Núñez; Jessica Ruiz-Medina; M Luisa Laorden; Olga Valverde; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Increased motivation to eat in opiate-withdrawn mice.

Authors:  Khalil Rouibi; Angelo Contarino
Journal:  Psychopharmacology (Berl)       Date:  2011-12-30       Impact factor: 4.530

3.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

4.  Hypoactivity of the hypothalamo-pituitary-adrenocortical axis during recovery from chronic variable stress.

Authors:  Michelle M Ostrander; Yvonne M Ulrich-Lai; Dennis C Choi; Neil M Richtand; James P Herman
Journal:  Endocrinology       Date:  2006-01-05       Impact factor: 4.736

5.  Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration.

Authors:  Fabien M Décaillot; Fa-Yun Che; Lloyd D Fricker; Lakshmi A Devi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint.

Authors:  Michelle T Foster; James P Warne; Abigail B Ginsberg; Hart F Horneman; Norman C Pecoraro; Susan F Akana; Mary F Dallman
Journal:  Endocrinology       Date:  2008-12-23       Impact factor: 4.736

Review 7.  Stress and eating behaviors.

Authors:  Y H C Yau; M N Potenza
Journal:  Minerva Endocrinol       Date:  2013-09       Impact factor: 2.184

8.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 9.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

10.  Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.

Authors:  Francesco Papaleo; Sandy Ghozland; Manuela Ingallinesi; Amanda J Roberts; George F Koob; Angelo Contarino
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.